Первично-множественная опухоль гемопоэтической ткани: миелоидная саркома в сочетании с лимфомой из клеток мантийной зоны. Клиническое наблюдение - Журнал Терапевтический архив №7 Вопросы гематологии 2021
Первично-множественная опухоль гемопоэтической ткани: миелоидная саркома в сочетании с лимфомой из клеток мантийной зоны. Клиническое наблюдение
Гаврилина О.А., Дубов В.С., Троицкая В.В., Ковригина А.М., Двирнык В.Н., Гальцева И.В., Судариков А.Б., Обухова Т.Н., Паровичникова Е.Н., Савченко В.Г. Первично-множественная опухоль гемопоэтической ткани: миелоидная саркома в сочетании с лимфомой из клеток мантийной зоны. Клиническое наблюдение. Терапевтический архив. 2021; 93 (7): 793–799. DOI: 10.26442/00403660.2021.07.200947
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Распространенность первично-множественных опухолей в последнее время значимо выросла, но вопрос выбора оптимальной тактики терапии при данной нозологии по-прежнему остается нерешенным. Особый интерес представляет одномоментное, или симультанное, выявление двух новообразований родственного происхождения в одном и том же очаге или очагах поражения. В данной публикации представлен случай одномоментной диагностики миелоидной саркомы и лимфомы из клеток мантийной зоны у больной 65 лет, потребовавший последовательного применения двух различных подходов и схем химиотерапии. Этот пример демонстрирует необходимость внедрения расширенного диагностического подхода с применением гистологических, иммуногистохимических, цитогенетических, молекулярных методов исследования на всех этапах диагностики и лечения, что позволяет своевременно выбрать правильную тактику терапии и достичь полной ремиссии при длительных сроках наблюдения по двум новообразованиям при первично-множественных опухолях.
Ключевые слова: миелоидная саркома, лимфома из клеток мантийной зоны, первично-множественные опухоли, иммуногистохимическое исследование, молекулярное исследование, цитогенетическое исследование
Keywords: myeloid sarcoma, mantle cell lymphoma, primary multiple tumors, immunohistochemistry study, molecular study
Ключевые слова: миелоидная саркома, лимфома из клеток мантийной зоны, первично-множественные опухоли, иммуногистохимическое исследование, молекулярное исследование, цитогенетическое исследование
________________________________________________
Keywords: myeloid sarcoma, mantle cell lymphoma, primary multiple tumors, immunohistochemistry study, molecular study
Список литературы
1. Billroth T, Reimer G. 51 Vorlesungen-Ein Handbuch fur Studierende and Artze, 14. 1889.
2. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with atleast three tumours. Eur J Surg Onoclo. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
3. Das S. Synchronous and Metachronous Cancers: An Update. Ann Clin Case Rep. 2017;1388:33. DOI: 10.1159/000507433
4. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
5. Crail HW. Multiple primary malignancies arising in the rectum, brain, and thyroid; report of a case. U S Nav Med Bull. 1949;49(1):123-8.
6. Noh SK, Yoon JY, Ryoo UN, et al. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol. 2008;19(4):265-9. DOI:10.3802/jgo.2008.19.4.265
7. Németh Z, Czigner J, Iván L, et al. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma. 2002;49(6):412-4. Available at: https://pubmed.ncbi.nlm.nih.gov/12584590. Accessed: 23.06.21
8. Sumoza LD, Messinger M, Sumoza P, et al. Concurrent Tumors in Patients with Hematologic Malignancies. Blood. 2014;124(21):5997. DOI:10.1182/blood.v124.21.5997.5997
9. Степанова Ю.А., Калинин Д.В., Вишневский В.А. Первично-множественные опухоли (обзор литературы). Медицинская визуализация. 2015;6:93-102. Режим доступа: https://medvis.vidar.ru/jour/article/view/167/168. Ссылка активна на 23.06.21 [Stepanova YuA, Kalinin DV, Vishnevsky VA. Multiple Primary Neoplasms (Literature Review). Medical Visualization. 2015;6:93-102. Available at: https://medvis.vidar.ru/jour/article/view/167/168. Accessed: 23.06.21 (in Russian)].
10. Breccia M, Alimena G. Isolated myeloid sarcoma without bone marrow involvement. Clin Adv Hematol Oncol. 2012;10(1):66-7.
11. Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34-43. DOI:10.1182/blood-2011-04-347872
12. Tsimberidou AM, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100-3. DOI:10.1038/sj.leu.2402958
13. Chan JK, Lau WH, Saw D. Extradural granulocytic sarcoma of the spine: a unique case of long survival after local therapy. Am J Hematol. 1986;22(4):439-41. DOI:10.1002/ajh.2830220415
14. Гаврилина О.А., Барях Е.А., Паровичникова Е.Н., и др. Миелоидная саркома тонкой кишки с инверсией 16-й хромосомы: описание 3 клинических случаев. Терапевтический архив. 2014;86(7):85-92. Режим доступа: https://ter-arkhiv.ru/0040-3660/article/view/31558. Ссылка активна на 23.06.21 [Gavrilina OA, Bariakh EA, Parovichnikova EN, et al. Myeloid sarcoma of the small intestine with inversion of the 16th chromosome: description of 3 clinical cases. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(7):85-92. Available at: https://ter-arkhiv.ru/0040-3660/article/view/31558. Accessed: 23.06.21 (in Russian)].
15. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800-16. DOI:10.1200/jco.1995.13.7.1800
16. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739-46. DOI:10.1002/cncr.10399
17. Banik S, Grech AB, Eyden BP. Granulocytic sarcoma of the cervix: an immunohistochemical, histochemical, and ultrastructural study. J Clin Pathol. 1989;42:483-8. DOI:10.1136/jcp.42.5.483
18. Astall E, Yarranton H, Arno J, Marcus R. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34. J Clin Pathol. 1999;52(9):705-7. DOI:10.1136/jcp.52.9.705
19. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma classification project. Blood. 1997;89(11):3909-18. DOI:10.1182/blood.V89.11.3909
20. Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131(1):29-38. DOI:10.1111/j.1365-2141.2005.05716.x
21. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12(8):1281-7. DOI:10.1038/sj.leu.2401121
22. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97(3):586-91. DOI:10.1002/cncr.11096
23. Swerdlow SH, E Campo, SA Pileri, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours Online. 2008:439. Available at: https://www.researchgate.net/publication/215837883_WHO_Classification_of_Tumours_of_the_Haematopoiet.... Accessed: 23.06.21
24. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3(2):185‑97. DOI:10.1016/s1535-6108(03)00028-x
25. Fernàndez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408-18. DOI:10.1158/0008-5472.can-09-3419
26. Королева Д.А., Габеева Н.Г., Кузьмина Л.А., и др. Негативное влияние мутаций в гене ТР53 на эффективность терапии лимфомы из клеток мантии. Промежуточные результаты протокола «ЛКМ-2016». Гематология и трансфузиология. 2019;64(3):256-73 [Koroleva DA, Gabeeva NG, Kuzmina LA, et al. Negative impact of the TP53 gene mutations on the efficacy of the therapy of mantle cell lymphoma. interim results of the mcl-2016 protocol. Russian Journal of Hematology and Transfusiology. 2019;64(3):256-73 (in Russian)]. DOI:10.35754/0234-5730-2019-64-3-256-273
27. Pawarode A, Baer MR, Padmanabhan S, et al. Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature. Leuk lymphoma. 2005;46(12):1813-8. DOI:10.1080/10428190500244258
28. Li S, Mann KP, Holden JT. Composite small lymphocytic lymphoma and extra-medullary myeloid tumor: a potential diagnostic pitfall. Int J Clin Exp Pathol. 2008;1(1):91-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480536. Accessed: 23.06.21
29. Paessler M, Choi J. Relapsed nodular sclerosis Hodgkin lymphoma and therapy-related myeloid sarcoma in a mediastinal mass. Blood. 2014;123(9):1291. DOI:10.1182/blood-2013-11-539890
30. Chevallier P, Labopin M, Cornelissen JJ, et al. Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT. Blood. 2010;116(21):4558-8.
DOI:10.1182/blood.v116.21.4558.4558
2. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with atleast three tumours. Eur J Surg Onoclo. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
3. Das S. Synchronous and Metachronous Cancers: An Update. Ann Clin Case Rep. 2017;1388:33. DOI: 10.1159/000507433
4. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
5. Crail HW. Multiple primary malignancies arising in the rectum, brain, and thyroid; report of a case. U S Nav Med Bull. 1949;49(1):123-8.
6. Noh SK, Yoon JY, Ryoo UN, et al. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol. 2008;19(4):265-9. DOI:10.3802/jgo.2008.19.4.265
7. Németh Z, Czigner J, Iván L, et al. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma. 2002;49(6):412-4. Available at: https://pubmed.ncbi.nlm.nih.gov/12584590. Accessed: 23.06.21
8. Sumoza LD, Messinger M, Sumoza P, et al. Concurrent Tumors in Patients with Hematologic Malignancies. Blood. 2014;124(21):5997. DOI:10.1182/blood.v124.21.5997.5997
9. Stepanova YuA, Kalinin DV, Vishnevsky VA. Multiple Primary Neoplasms (Literature Review). Medical Visualization. 2015;6:93-102. Available at: https://medvis.vidar.ru/jour/article/view/167/168. Accessed: 23.06.21 (in Russian)
10. Breccia M, Alimena G. Isolated myeloid sarcoma without bone marrow involvement. Clin Adv Hematol Oncol. 2012;10(1):66-7.
11. Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34-43. DOI:10.1182/blood-2011-04-347872
12. Tsimberidou AM, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100-3. DOI:10.1038/sj.leu.2402958
13. Chan JK, Lau WH, Saw D. Extradural granulocytic sarcoma of the spine: a unique case of long survival after local therapy. Am J Hematol. 1986;22(4):439-41. DOI:10.1002/ajh.2830220415
14. Gavrilina OA, Bariakh EA, Parovichnikova EN, et al. Myeloid sarcoma of the small intestine with inversion of the 16th chromosome: description of 3 clinical cases. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(7):85-92. Available at: https://ter-arkhiv.ru/0040-3660/article/view/31558. Accessed: 23.06.21 (in Russian)
15. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800-16. DOI:10.1200/jco.1995.13.7.1800
16. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739-46. DOI:10.1002/cncr.10399
17. Banik S, Grech AB, Eyden BP. Granulocytic sarcoma of the cervix: an immunohistochemical, histochemical, and ultrastructural study. J Clin Pathol. 1989;42:483-8. DOI:10.1136/jcp.42.5.483
18. Astall E, Yarranton H, Arno J, Marcus R. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34. J Clin Pathol. 1999;52(9):705-7. DOI:10.1136/jcp.52.9.705
19. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma classification project. Blood. 1997;89(11):3909-18. DOI:10.1182/blood.V89.11.3909
20. Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131(1):29-38. DOI:10.1111/j.1365-2141.2005.05716.x
21. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12(8):1281-7. DOI:10.1038/sj.leu.2401121
22. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97(3):586-91. DOI:10.1002/cncr.11096
23. Swerdlow SH, E Campo, SA Pileri, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours Online. 2008:439. Available at: https://www.researchgate.net/publication/215837883_WHO_Classification_of_Tumours_of_the_Haematopoiet.... Accessed: 23.06.21
24. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3(2):185‑97. DOI:10.1016/s1535-6108(03)00028-x
25. Fernàndez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408-18. DOI:10.1158/0008-5472.can-09-3419
26. Koroleva DA, Gabeeva NG, Kuzmina LA, et al. Negative impact of the TP53 gene mutations on the efficacy of the therapy of mantle cell lymphoma. interim results of the mcl-2016 protocol. Russian Journal of Hematology and Transfusiology. 2019;64(3):256-73 (in Russian) DOI:10.35754/0234-5730-2019-64-3-256-273
27. Pawarode A, Baer MR, Padmanabhan S, et al. Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature. Leuk lymphoma. 2005;46(12):1813-8. DOI:10.1080/10428190500244258
28. Li S, Mann KP, Holden JT. Composite small lymphocytic lymphoma and extra-medullary myeloid tumor: a potential diagnostic pitfall. Int J Clin Exp Pathol. 2008;1(1):91-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480536. Accessed: 23.06.21
29. Paessler M, Choi J. Relapsed nodular sclerosis Hodgkin lymphoma and therapy-related myeloid sarcoma in a mediastinal mass. Blood. 2014;123(9):1291. DOI:10.1182/blood-2013-11-539890
30. Chevallier P, Labopin M, Cornelissen JJ, et al. Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT. Blood. 2010;116(21):4558-8.
DOI:10.1182/blood.v116.21.4558.4558
2. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with atleast three tumours. Eur J Surg Onoclo. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
3. Das S. Synchronous and Metachronous Cancers: An Update. Ann Clin Case Rep. 2017;1388:33. DOI: 10.1159/000507433
4. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
5. Crail HW. Multiple primary malignancies arising in the rectum, brain, and thyroid; report of a case. U S Nav Med Bull. 1949;49(1):123-8.
6. Noh SK, Yoon JY, Ryoo UN, et al. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol. 2008;19(4):265-9. DOI:10.3802/jgo.2008.19.4.265
7. Németh Z, Czigner J, Iván L, et al. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma. 2002;49(6):412-4. Available at: https://pubmed.ncbi.nlm.nih.gov/12584590. Accessed: 23.06.21
8. Sumoza LD, Messinger M, Sumoza P, et al. Concurrent Tumors in Patients with Hematologic Malignancies. Blood. 2014;124(21):5997. DOI:10.1182/blood.v124.21.5997.5997
9. Степанова Ю.А., Калинин Д.В., Вишневский В.А. Первично-множественные опухоли (обзор литературы). Медицинская визуализация. 2015;6:93-102. Режим доступа: https://medvis.vidar.ru/jour/article/view/167/168. Ссылка активна на 23.06.21 [Stepanova YuA, Kalinin DV, Vishnevsky VA. Multiple Primary Neoplasms (Literature Review). Medical Visualization. 2015;6:93-102. Available at: https://medvis.vidar.ru/jour/article/view/167/168. Accessed: 23.06.21 (in Russian)].
10. Breccia M, Alimena G. Isolated myeloid sarcoma without bone marrow involvement. Clin Adv Hematol Oncol. 2012;10(1):66-7.
11. Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34-43. DOI:10.1182/blood-2011-04-347872
12. Tsimberidou AM, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100-3. DOI:10.1038/sj.leu.2402958
13. Chan JK, Lau WH, Saw D. Extradural granulocytic sarcoma of the spine: a unique case of long survival after local therapy. Am J Hematol. 1986;22(4):439-41. DOI:10.1002/ajh.2830220415
14. Гаврилина О.А., Барях Е.А., Паровичникова Е.Н., и др. Миелоидная саркома тонкой кишки с инверсией 16-й хромосомы: описание 3 клинических случаев. Терапевтический архив. 2014;86(7):85-92. Режим доступа: https://ter-arkhiv.ru/0040-3660/article/view/31558. Ссылка активна на 23.06.21 [Gavrilina OA, Bariakh EA, Parovichnikova EN, et al. Myeloid sarcoma of the small intestine with inversion of the 16th chromosome: description of 3 clinical cases. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(7):85-92. Available at: https://ter-arkhiv.ru/0040-3660/article/view/31558. Accessed: 23.06.21 (in Russian)].
15. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800-16. DOI:10.1200/jco.1995.13.7.1800
16. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739-46. DOI:10.1002/cncr.10399
17. Banik S, Grech AB, Eyden BP. Granulocytic sarcoma of the cervix: an immunohistochemical, histochemical, and ultrastructural study. J Clin Pathol. 1989;42:483-8. DOI:10.1136/jcp.42.5.483
18. Astall E, Yarranton H, Arno J, Marcus R. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34. J Clin Pathol. 1999;52(9):705-7. DOI:10.1136/jcp.52.9.705
19. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma classification project. Blood. 1997;89(11):3909-18. DOI:10.1182/blood.V89.11.3909
20. Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131(1):29-38. DOI:10.1111/j.1365-2141.2005.05716.x
21. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12(8):1281-7. DOI:10.1038/sj.leu.2401121
22. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97(3):586-91. DOI:10.1002/cncr.11096
23. Swerdlow SH, E Campo, SA Pileri, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours Online. 2008:439. Available at: https://www.researchgate.net/publication/215837883_WHO_Classification_of_Tumours_of_the_Haematopoiet.... Accessed: 23.06.21
24. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3(2):185‑97. DOI:10.1016/s1535-6108(03)00028-x
25. Fernàndez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408-18. DOI:10.1158/0008-5472.can-09-3419
26. Королева Д.А., Габеева Н.Г., Кузьмина Л.А., и др. Негативное влияние мутаций в гене ТР53 на эффективность терапии лимфомы из клеток мантии. Промежуточные результаты протокола «ЛКМ-2016». Гематология и трансфузиология. 2019;64(3):256-73 [Koroleva DA, Gabeeva NG, Kuzmina LA, et al. Negative impact of the TP53 gene mutations on the efficacy of the therapy of mantle cell lymphoma. interim results of the mcl-2016 protocol. Russian Journal of Hematology and Transfusiology. 2019;64(3):256-73 (in Russian)]. DOI:10.35754/0234-5730-2019-64-3-256-273
27. Pawarode A, Baer MR, Padmanabhan S, et al. Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature. Leuk lymphoma. 2005;46(12):1813-8. DOI:10.1080/10428190500244258
28. Li S, Mann KP, Holden JT. Composite small lymphocytic lymphoma and extra-medullary myeloid tumor: a potential diagnostic pitfall. Int J Clin Exp Pathol. 2008;1(1):91-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480536. Accessed: 23.06.21
29. Paessler M, Choi J. Relapsed nodular sclerosis Hodgkin lymphoma and therapy-related myeloid sarcoma in a mediastinal mass. Blood. 2014;123(9):1291. DOI:10.1182/blood-2013-11-539890
30. Chevallier P, Labopin M, Cornelissen JJ, et al. Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT. Blood. 2010;116(21):4558-8.
DOI:10.1182/blood.v116.21.4558.4558
________________________________________________
2. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with atleast three tumours. Eur J Surg Onoclo. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
3. Das S. Synchronous and Metachronous Cancers: An Update. Ann Clin Case Rep. 2017;1388:33. DOI: 10.1159/000507433
4. Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol. 2001;27(3):302-13. DOI:10.1053/ejso.2001.1112
5. Crail HW. Multiple primary malignancies arising in the rectum, brain, and thyroid; report of a case. U S Nav Med Bull. 1949;49(1):123-8.
6. Noh SK, Yoon JY, Ryoo UN, et al. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol. 2008;19(4):265-9. DOI:10.3802/jgo.2008.19.4.265
7. Németh Z, Czigner J, Iván L, et al. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma. 2002;49(6):412-4. Available at: https://pubmed.ncbi.nlm.nih.gov/12584590. Accessed: 23.06.21
8. Sumoza LD, Messinger M, Sumoza P, et al. Concurrent Tumors in Patients with Hematologic Malignancies. Blood. 2014;124(21):5997. DOI:10.1182/blood.v124.21.5997.5997
9. Stepanova YuA, Kalinin DV, Vishnevsky VA. Multiple Primary Neoplasms (Literature Review). Medical Visualization. 2015;6:93-102. Available at: https://medvis.vidar.ru/jour/article/view/167/168. Accessed: 23.06.21 (in Russian)
10. Breccia M, Alimena G. Isolated myeloid sarcoma without bone marrow involvement. Clin Adv Hematol Oncol. 2012;10(1):66-7.
11. Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34-43. DOI:10.1182/blood-2011-04-347872
12. Tsimberidou AM, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100-3. DOI:10.1038/sj.leu.2402958
13. Chan JK, Lau WH, Saw D. Extradural granulocytic sarcoma of the spine: a unique case of long survival after local therapy. Am J Hematol. 1986;22(4):439-41. DOI:10.1002/ajh.2830220415
14. Gavrilina OA, Bariakh EA, Parovichnikova EN, et al. Myeloid sarcoma of the small intestine with inversion of the 16th chromosome: description of 3 clinical cases. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(7):85-92. Available at: https://ter-arkhiv.ru/0040-3660/article/view/31558. Accessed: 23.06.21 (in Russian)
15. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800-16. DOI:10.1200/jco.1995.13.7.1800
16. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739-46. DOI:10.1002/cncr.10399
17. Banik S, Grech AB, Eyden BP. Granulocytic sarcoma of the cervix: an immunohistochemical, histochemical, and ultrastructural study. J Clin Pathol. 1989;42:483-8. DOI:10.1136/jcp.42.5.483
18. Astall E, Yarranton H, Arno J, Marcus R. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34. J Clin Pathol. 1999;52(9):705-7. DOI:10.1136/jcp.52.9.705
19. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma classification project. Blood. 1997;89(11):3909-18. DOI:10.1182/blood.V89.11.3909
20. Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131(1):29-38. DOI:10.1111/j.1365-2141.2005.05716.x
21. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12(8):1281-7. DOI:10.1038/sj.leu.2401121
22. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97(3):586-91. DOI:10.1002/cncr.11096
23. Swerdlow SH, E Campo, SA Pileri, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours Online. 2008:439. Available at: https://www.researchgate.net/publication/215837883_WHO_Classification_of_Tumours_of_the_Haematopoiet.... Accessed: 23.06.21
24. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3(2):185‑97. DOI:10.1016/s1535-6108(03)00028-x
25. Fernàndez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408-18. DOI:10.1158/0008-5472.can-09-3419
26. Koroleva DA, Gabeeva NG, Kuzmina LA, et al. Negative impact of the TP53 gene mutations on the efficacy of the therapy of mantle cell lymphoma. interim results of the mcl-2016 protocol. Russian Journal of Hematology and Transfusiology. 2019;64(3):256-73 (in Russian) DOI:10.35754/0234-5730-2019-64-3-256-273
27. Pawarode A, Baer MR, Padmanabhan S, et al. Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature. Leuk lymphoma. 2005;46(12):1813-8. DOI:10.1080/10428190500244258
28. Li S, Mann KP, Holden JT. Composite small lymphocytic lymphoma and extra-medullary myeloid tumor: a potential diagnostic pitfall. Int J Clin Exp Pathol. 2008;1(1):91-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480536. Accessed: 23.06.21
29. Paessler M, Choi J. Relapsed nodular sclerosis Hodgkin lymphoma and therapy-related myeloid sarcoma in a mediastinal mass. Blood. 2014;123(9):1291. DOI:10.1182/blood-2013-11-539890
30. Chevallier P, Labopin M, Cornelissen JJ, et al. Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT. Blood. 2010;116(21):4558-8.
DOI:10.1182/blood.v116.21.4558.4558
Авторы
О.А. Гаврилина*, В.С. Дубов, В.В. Троицкая, А.М. Ковригина, В.Н. Двирнык, И.В. Гальцева, А.Б. Судариков, Т.Н. Обухова, Е.Н. Паровичникова, В.Г. Савченко
ФГБУ «Национальный медицинский исследовательский центр гематологии» Минздрава России, Москва, Россия
*dr.gavrilina@mail.ru
National Medical Research Center for Hematology, Moscow, Russia
*dr.gavrilina@mail.ru
ФГБУ «Национальный медицинский исследовательский центр гематологии» Минздрава России, Москва, Россия
*dr.gavrilina@mail.ru
________________________________________________
National Medical Research Center for Hematology, Moscow, Russia
*dr.gavrilina@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.